Rankings
▼
Calendar
BMRN Q1 2024 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$649M
+8.8% YoY
Gross Profit
$524M
80.7% margin
Operating Income
$88M
13.6% margin
Net Income
$89M
13.7% margin
EPS (Diluted)
$0.46
QoQ Revenue Growth
+0.4%
Cash Flow
Operating Cash Flow
$47M
Free Cash Flow
$13M
Stock-Based Comp.
$58M
Balance Sheet
Total Assets
$6.9B
Total Liabilities
$1.8B
Stockholders' Equity
$5.1B
Cash & Equivalents
$747M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$649M
$596M
+8.8%
Gross Profit
$524M
$461M
+13.6%
Operating Income
$88M
$62M
+41.8%
Net Income
$89M
$51M
+74.4%
Revenue Segments
Product
$638M
98%
Royalty And Other
$11M
2%
← FY 2024
All Quarters
Q2 2024 →